📌 X Insight Update[x_fin] (2026/03/10 05:37)
- Novo Nordisk’s entry with Wegovy and Ozempic on the Hims & Hers platform forced Hims & Hers to drop its GLP-1 alternative promotion. This highlights the ruthless nature of market competition: “no permanent friends, only permanent interests.” [引用[1]](https://x.